- $4.35bn
- $18.02bn
- BRL39.47bn
- 79
- 94
- 56
- 90
2019 December 31st | 2020 December 31st | C2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13,560 | 13,509 | 24,907 | 39,323 | 39,468 |
Cost of Revenue | |||||
Gross Profit | 3,972 | 3,693 | 5,784 | 8,766 | 10,919 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,961 | 11,080 | 16,231 | 31,512 | 26,458 |
Operating Profit | 3,600 | 2,429 | 8,676 | 7,811 | 13,011 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,201 | 1,167 | 5,900 | 2,653 | 5,114 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,472 | 909 | 6,351 | 2,771 | 4,839 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,425 | 852 | 6,123 | 1,176 | 1,094 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,425 | 852 | 6,123 | 1,176 | 1,094 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 0.53 | 3.17 | 0.947 | 0.798 |
Dividends per Share |